Actos Articles

Actos approval shortly?

16 July 1999

Eli Lilly: Correction

15 July 1999

GW pipeline update reveals few drop-outs and steady progress

8 July 1999

Japanese pharmaceutical industry and firms reviewed by HSBC analysts

25 June 1999

Labeling strengthened for Rezulin in wake of Avandia launch

23 June 1999

Lilly/Takeda's Actos: first efficacy data presented at ADA

23 June 1999

Beyond Prozac : Lilly outlines future

14 June 1999

Japanese drugmakers setting conservative targets for fiscal 2000

7 June 1999

Stock Commentary Tokyo

3 June 1999

Avandia approved in USA as competitor to Rezulin in diabetes market

27 May 1999

Stock Commentary Tokyo

27 May 1999

Diabetes market to reach $20 billion a year by 2006, says Lehman Brothers

26 May 1999

Strong net profits growth for Sankyo

24 May 1999

Worst may to be over for Europe's pharma stocks, but analysts remain

14 May 1999

Novo Nordisk posts solid first-quarter sales

13 May 1999

Stock Commentary Tokyo

13 May 1999

US pharmaceutical firms weigh in with strong sales and earnings growth

29 April 1999

Stock Commentary Tokyo

29 April 1999

Analysts compare and contrast new glitazones from SB and Takeda

29 April 1999

SB boosted as Avandia is backed by FDA advisory panel; links with B-MS for

26 April 1999

SB boosted as Avandia is backed by FDA advisory panel

23 April 1999

Stock Commentary Tokyo

22 April 1999

UK drug stock's rebound sustainable, says Commerzbank

13 April 1999

TAP Holdings posts strong sales growth

8 April 1999

Priority review for Takeda's Actos in USA

18 March 1999

Stock Commentary Tokyo

18 March 1999

Stock Commentary Tokyo

11 March 1999

Stock Commentary Tokyo

4 March 1999

Troglitazone; great potential despite woes

18 February 1999

Takeda entering new phase of global expansion, says MSDW analyst

18 February 1999

Stock Commentary Tokyo

28 January 1999

SB's Avandia gets priority US review

27 January 1999

SB's Avandia gets priority US review

22 January 1999

Rezulin up for FDA panel review on safety, plus new indications

19 January 1999

Correction - pioglitazone

13 January 1999

AstraZeneca's Effect On Rest Of Pharma Sector

17 December 1998

Takeda Pharma Sets Up Swiss Subsidiary

11 September 1998

Analysts Backing Takeda As US Sales Grow

14 April 1998

Takeda, Diabetes Drive Japanese Blockbusters

19 February 1998

Troglitazone Launched In Japan; 1st Market

20 March 1997

First Filing For Pioglitazone

27 January 1997

Showing 301-341 of 341 articles

Go to beginningPreviousNextGo to end